Spondylo-arthritis Screening Tool Among Patient Suffering From Inflammatory Bowel Disease

Condition(s) studied

Investigational drug(s) / intervention(s)

Screening questionnaire: Every patient will answer the 2 screening questionnaires given to them, once at baseline and a second time after 1 month.

Study summary

The QUESAM study aims to translate into French and validate the traduction of 2 screening questionnaires for spondylo-arthritis among people with inflammatory bowel disease.

DETAIL (DETection of Arthritis in Inflammatory boweL diseases) and IBIS-Q (Inflammatory Bowel disease Identification of Spondyloarthritis Questionnaire) questionnaires are built to determine which patients might benefit from a rheumatologic consultation, for a potential rheumatologic inflammatory disease.

The investigators will translate the 2 questionnaire in french thanks to an external translation company, from english to french, then back to english to make sure the translation is correct.

Then, the main question is:

is there a conceptual and semantic equivalence beetween the original english questionnaire and the french-translated one.

Participant will answer the 2 screening questionnaire, one initial time during a consultation, and a second time after 1 month.

Eligibility

Primary outcome measure(s)

• translation and cross-cultural adaptation in french of the questionnaires developped by Di Marco et al (2017) and Variola et al (2020) — 13 months
  This is a composite criterion combining conceptual equivalence and semantic equivalence of items between the transcultural adaptation of the scale and its original version. Conceptual equivalence will be judged on the results of factorial analysis (exploratory and confirmatory). Semantic equivalence of items will be based on evaluation by a panel of experts.

Trial sites (1)

More University Hospital, Grenoble trials in France

Other trials for the same condition